HilleVax, Inc. (NASDAQ:HLVX) Short Interest Update
HilleVax, Inc. (NASDAQ:HLVX) Short Interest Update
HilleVax, Inc. (NASDAQ:HLVX – Get Rating) was the target of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 737,700 shares, an increase of 28.5% from the October 15th total of 574,100 shares. Based on an average daily trading volume, of 67,900 shares, the short-interest ratio is presently 10.9 days. Approximately 5.6% of the shares of the company are sold short.
10月份，新浪空頭股數大幅上漲的目標是希爾瓦克斯公司。截至10月31日，空頭股數共有737,700股，比10月15日的574,100股增加了28.5%。以日均成交量六萬七千九百股計算，目前短息比率為十點九日。該公司約5.6%的股份被賣空。
Institutional Investors Weigh In On HilleVax
機構投資者買入HilleVax
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Frazier Life Sciences Management L.P. bought a new position in HilleVax in the 2nd quarter worth $101,493,000. Deerfield Management Company L.P. Series C bought a new position in HilleVax in the 2nd quarter worth $28,614,000. Price T Rowe Associates Inc. MD bought a new position in HilleVax in the 2nd quarter worth $12,037,000. Franklin Resources Inc. bought a new position in HilleVax in the 2nd quarter worth $7,351,000. Finally, State Street Corp bought a new position in HilleVax in the 2nd quarter worth $1,794,000.
幾家對衝基金和其他機構投資者最近調整了對該股的持有量。弗雷澤生命科學管理公司在第二季度購買了價值101,493,000美元的HilleVax新頭寸。Deerfield Management Company L.P.C系列在第二季度購買了HilleVax的一個新頭寸，價值28,614,000美元。Price T Rowe Associates Inc.MD在第二季度購買了價值12,037,000美元的HilleVax新頭寸。富蘭克林資源公司(Franklin Resources Inc.)在第二季度購買了價值7,351,000美元的HilleVax新頭寸。最後，道富集團在第二季度購買了價值1,794,000美元的HilleVax新頭寸。
HilleVax Trading Down 7.9 %
HilleVax降價7.9%
Shares of NASDAQ:HLVX traded down $1.65 during midday trading on Friday, hitting $19.23. The company had a trading volume of 164,877 shares, compared to its average volume of 89,586. The company has a debt-to-equity ratio of 0.02, a current ratio of 25.54 and a quick ratio of 25.54. HilleVax has a 12-month low of $7.90 and a 12-month high of $24.42. The business has a fifty day simple moving average of $19.02.
納斯達克：HLVX股價週五午盤下跌1.65美元，至19.23美元。該公司的成交量為164,877股，而其平均成交量為89,586股。該公司的負債權益比為0.02，流動比率為25.54，速動比率為25.54。HilleVax的12個月低點為7.90美元，12個月高位為24.42美元。該業務的50日簡單移動均線切入位為19.02美元。
About HilleVax
關於HilleVax
(Get Rating)
(獲取評級)
HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
HilleVax，Inc.是一家臨牀階段的生物製藥公司，專注於開發和商業化新型疫苗。該公司正在開發HIL-214，這是一種基於病毒樣顆粒的候選疫苗，用於預防由諾沃克病毒感染引起的中到重度急性胃腸炎。該公司總部設在馬薩諸塞州波士頓。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on HilleVax (HLVX)
- MarketBeat: Week in Review 11/7 – 11/11
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- 免費獲取StockNews.com關於HilleVax的研究報告(HLVX)
- MarketBeat：回顧中的一週11/7-11/11
- 油價是股市拋售尚未結束的一個令人信服的原因
- 中盤Neurocrine生物科學是井噴後的第三季度報告嗎？
- 六面旗幟是一種你不想被困住的旅程
- 願景氫，現在的願景能源，將希望寄託在股票拆分上
Receive News & Ratings for HilleVax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HilleVax and related companies with MarketBeat.com's FREE daily email newsletter.
接收HilleVax Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對HilleVax和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。